157 related articles for article (PubMed ID: 12533881)
1. [Histopathological observation of experimental slight viral myocarditis].
Cheng J; Chen YC; Hu BJ; Zhang Y; Zeng JL; Liu Y
Fa Yi Xue Za Zhi; 2001 Feb; 17(1):4-6, 61. PubMed ID: 12533881
[TBL] [Abstract][Full Text] [Related]
2. [Expression of TGF-beta 1 and proliferation of collagen in myocardium in viral myocarditis].
Cheng J
Fa Yi Xue Za Zhi; 2000 Nov; 16(4):208-9, S1-2. PubMed ID: 12536967
[TBL] [Abstract][Full Text] [Related]
3. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
4. [Minor Bupleurum decoction in the treatment of viral myocarditis models].
Wang X; Zhang G; Liang Y; Chen C; Qiu S
Zhongguo Zhong Yao Za Zhi; 1997 Nov; 22(11):684-6, 704. PubMed ID: 11243188
[TBL] [Abstract][Full Text] [Related]
5. Experimental coxsackie B virus myocarditis in mice: 18 month histopathological and virological study.
Kutaura Y
Jpn Circ J; 1981 Jul; 45(7):747-62. PubMed ID: 6267334
[TBL] [Abstract][Full Text] [Related]
6. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis.
Kim JM; Lim BK; Ho SH; Yun SH; Shin JO; Park EM; Kim DK; Kim S; Jeon ES
Biochem Biophys Res Commun; 2006 Jun; 344(3):765-71. PubMed ID: 16631119
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological and pathological observations on experimental coxsackie B-3 viral myocarditis in mice.
Yang YZ; Guo Q; Zhou TS; Zhang J; Li L; Jin PY; Wu WZ; Shen JY; Yang JH; Peng BZ
Chin Med J (Engl); 1993 Feb; 106(2):100-4. PubMed ID: 8389271
[TBL] [Abstract][Full Text] [Related]
8. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis.
Latva-Hirvelä J; Kytö V; Saraste A; Eriksson S; Vuorinen T; Pettersson K; Saukko P
Eur J Clin Invest; 2009 Jun; 39(6):457-62. PubMed ID: 19397694
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of preventive effect of xin-kang oral liquid on acute viral myocarditis in mice].
Zhao H; Wan S; Xu X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):139-42. PubMed ID: 11436642
[TBL] [Abstract][Full Text] [Related]
12. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on basic fibroblast growth factors in viral myocarditis].
Zha G
Fa Yi Xue Za Zhi; 2000 Nov; 16(4):210, 213, S2. PubMed ID: 12536968
[TBL] [Abstract][Full Text] [Related]
14. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis.
Kytö V; Lapatto R; Lakkisto P; Saraste A; Voipio-Pulkki LM; Vuorinen T; Pulkki K
Eur J Clin Invest; 2004 Mar; 34(3):167-75. PubMed ID: 15025674
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental Coxsackie B-3 viral myocarditis with Astragalus membranaceus in mice.
Yang YZ; Jin PY; Guo Q; Wu WZ; Pu SY; Chen HZ; Yang JH; Wang KQ; Shi JY; Gong ZX
Chin Med J (Engl); 1990 Jan; 103(1):14-8. PubMed ID: 2161724
[TBL] [Abstract][Full Text] [Related]
16. [A pathologic and ultrastructural study of Coxsackie B3 myocarditis in mice].
Lin JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Jun; 16(3):159-60. PubMed ID: 2851428
[No Abstract] [Full Text] [Related]
17. Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle.
Matsumori A; Kawai C
J Pathol; 1980 Jun; 131(2):97-106. PubMed ID: 6253611
[TBL] [Abstract][Full Text] [Related]
18. [Effects of T-activin in viral myocarditis in animal experiments].
Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
[TBL] [Abstract][Full Text] [Related]
19. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
